Effect of sucralfate on experimental colitis in the rat
- PMID: 2914534
- DOI: 10.1007/BF02553817
Effect of sucralfate on experimental colitis in the rat
Abstract
The therapeutic effect of sucralfate on ulcerated gastric and duodenal mucosa is well known. There is, however, almost no information about its activity in colitis. Experimental colitis was produced in rats by rectal instillation of 1 ml of 10 percent acetic acid, and 1.5 ml of a 20 percent suspension of sucralfate was then administered every 12 hours for various lengths of time. Study animals and appropriate controls were killed after 3, 7, 10, or 14 days. The distal colons were studied macroscopically and histologically. Colonic prostaglandin E2 levels were measured in animals killed after 3, 7, 10, or 14 days. The macroscopic score was significantly improved 10 and 14 days after induction of colitis, although the histologic appearance was unchanged. Acetic acid administration increased and sucralfate treatment reduced prostaglandin E2 levels in colitic animals on days 3 and 7, but not later. The present study supports a role for sucralfate in the treatment of colitis, but further studies on the mechanism of its effect and on its clinical activity are indicated.
Similar articles
-
Therapeutic effect of colloid bismuth subcitrate in experimental colitis in the rat.Digestion. 1995;56(3):211-3. doi: 10.1159/000201245. Digestion. 1995. PMID: 7657046
-
Sucralfate is protective against indomethacin-induced intestinal ulceration in the rat.Digestion. 1988;41(2):78-82. doi: 10.1159/000199735. Digestion. 1988. PMID: 3220179
-
Influence of topical rectal application of drugs on dextran sulfate-induced colitis in rats.Dig Dis Sci. 1997 Apr;42(4):824-32. doi: 10.1023/a:1018880501437. Dig Dis Sci. 1997. PMID: 9125657
-
Evaluation of the application of enemas containing sucralfate in tissue content of neutral and acid mucins in experimental model of diversion colitis.Acta Cir Bras. 2014 Sep;29(9):544-52. doi: 10.1590/s0102-8650201400150001. Acta Cir Bras. 2014. PMID: 25252200
-
Inhibition of butyric acid-induced colitis in mice by 16,16-dimethyl prostaglandin E2.Agents Actions. 1992;Spec No:C79-81. Agents Actions. 1992. PMID: 1332452
Cited by
-
Non-surgical interventions for late rectal problems (proctopathy) of radiotherapy in people who have received radiotherapy to the pelvis.Cochrane Database Syst Rev. 2016 Apr 25;4(4):CD003455. doi: 10.1002/14651858.CD003455.pub2. Cochrane Database Syst Rev. 2016. PMID: 27111831 Free PMC article.
-
Natural history of late radiation proctosigmoiditis treated with topical sucralfate suspension.Dig Dis Sci. 1999 May;44(5):973-8. doi: 10.1023/a:1026612731210. Dig Dis Sci. 1999. PMID: 10235606
-
Sucralfate enemas reduce the oxidative tissue damage and preserves the contents of E-cadherin and ?-catenin in colonic mucosa without fecal stream.Acta Cir Bras. 2021 Nov 29;36(10):e361007. doi: 10.1590/ACB361007. eCollection 2021. Acta Cir Bras. 2021. PMID: 34852133 Free PMC article.
-
Sucralfate and methylprednisolone enemas in active ulcerative colitis: a prospective, single-blind study.Dig Dis Sci. 1999 Sep;44(9):1899-901. doi: 10.1023/a:1018863210931. Dig Dis Sci. 1999. PMID: 10505732 Clinical Trial.
-
Radiation-induced proctosigmoiditis. Prospective, randomized, double-blind controlled trial of oral sulfasalazine plus rectal steroids versus rectal sucralfate.Dig Dis Sci. 1991 Jan;36(1):103-7. doi: 10.1007/BF01300096. Dig Dis Sci. 1991. PMID: 1670631 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources